Zhuhai Peoples' Hospital Medical Group
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lu, Ligong
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
NCT05238649: Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine

Active, not recruiting
2
150
RoW
Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg, V-01 10μg, Recombinant SARS-CoV-2 Fusion Protein Vaccine 25μg, V-01 25μg, SARS-Cov-2 Vaccine Inactivated, Inactivated vaccine
Livzon Pharmaceutical Group Inc.
COVID-19 Pandemic
11/22
01/23
NCT05119647: A Single-Arm Objective Performance Criteria Trial for Intracranial Thrombus Aspiration Catheter

Completed
N/A
124
RoW
Thrombus Aspiration Catheter(Ton-bridgeMT)
Zhuhai Tonbridge Medical Tech. Co., Ltd.
Acute Ischemic Stroke
08/22
11/22
NCT05125874: Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization

Active, not recruiting
N/A
45
RoW
Recombinant SARS-CoV-2 Fusion Protein Vaccine, V-01
Livzon Pharmaceutical Group Inc.
COVID-19 Pandemic
08/23
09/23

Download Options